Selected research
Industry Growth & Trends
Global Felypressin Industry Growth and Trends Forecast to 2032
Market perspective
The global Felypressin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Felypressin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Felypressin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Felypressin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Felypressin include Peptide, WellMan, TargetMol, TaiTan, Maclin, Nanjing Peptide, Nanjing Leon, JunYu and AikonChem, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Felypressin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Felypressin market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Felypressin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Felypressin.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Felypressin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Felypressin Market by Company
Peptide
WellMan
TargetMol
TaiTan
Maclin
Nanjing Peptide
Nanjing Leon
JunYu
AikonChem
JuSheng
Sai Mannuo
Gotopbio
Mreda
Vulcanchem
Toronto Research Chemicals
Medical Isotopes
Glentham Life Sciences
Crysdot
ChemScene
CacheSyn
BOC Sciences
BIOTREND Chemicals AG
Felypressin Segment by Type
90% Purity
95% Purity
98% Purity
99% Purity
Felypressin Segment by Application
Medical
Health Products
Felypressin Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Felypressin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Felypressin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Felypressin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Felypressin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Felypressin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 90% Purity
- 95% Purity
- 98% Purity
- 99% Purity
Applications
- Medical
- Health Products
Companies covered
- Peptide
- WellMan
- TargetMol
- TaiTan
- Maclin
- Nanjing Peptide
- Nanjing Leon
- JunYu
- AikonChem
- JuSheng
- Sai Mannuo
- Gotopbio
- Mreda
- Vulcanchem
- Toronto Research Chemicals
- Medical Isotopes
- Glentham Life Sciences
- Crysdot
- ChemScene
- CacheSyn
- BOC Sciences
- BIOTREND Chemicals AG
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Felypressin Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Felypressin Sales Estimates and Forecasts (2021-2032)
- 1.3 Felypressin Market by Type
- 1.3.1 90% Purity
- 1.3.2 95% Purity
- 1.3.3 98% Purity
- 1.3.4 99% Purity
- 1.4 Global Felypressin Market Size by Type
- 1.4.1 Global Felypressin Market Size Overview by Type (2021-2032)
- 1.4.2 Global Felypressin Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Felypressin Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Felypressin Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Felypressin Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Felypressin Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Felypressin Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Felypressin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Felypressin Industry Trends
- 2.2 Felypressin Industry Drivers
- 2.3 Felypressin Industry Opportunities and Challenges
- 2.4 Felypressin Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Felypressin Revenue (2021-2026)
- 3.2 Global Top Players by Felypressin Sales (2021-2026)
- 3.3 Global Top Players by Felypressin Price (2021-2026)
- 3.4 Global Felypressin Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Felypressin Major Company Production Sites & Headquarters
- 3.6 Global Felypressin Company, Product Type & Application
- 3.7 Global Felypressin Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Felypressin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Felypressin Players Market Share by Revenue in 2025
- 3.8.3 2025 Felypressin Tier 1, Tier 2, and Tier 3
4 Felypressin Regional Status and Outlook
- 4.1 Global Felypressin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Felypressin Historic Market Size by Region
- 4.2.1 Global Felypressin Sales in Volume by Region (2021-2026)
- 4.2.2 Global Felypressin Sales in Value by Region (2021-2026)
- 4.2.3 Global Felypressin Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Felypressin Forecasted Market Size by Region
- 4.3.1 Global Felypressin Sales in Volume by Region (2027-2032)
- 4.3.2 Global Felypressin Sales in Value by Region (2027-2032)
- 4.3.3 Global Felypressin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Felypressin by Application
- 5.1 Felypressin Market by Application
- 5.1.1 Medical
- 5.1.2 Health Products
- 5.2 Global Felypressin Market Size by Application
- 5.2.1 Global Felypressin Market Size Overview by Application (2021-2032)
- 5.2.2 Global Felypressin Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Felypressin Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Felypressin Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Felypressin Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Felypressin Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Felypressin Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Felypressin Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Peptide
- 6.1.1 Peptide Company Information
- 6.1.2 Peptide Business Overview
- 6.1.3 Peptide Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Peptide Felypressin Product Portfolio
- 6.1.5 Peptide Recent Developments
- 6.2 WellMan
- 6.2.1 WellMan Company Information
- 6.2.2 WellMan Business Overview
- 6.2.3 WellMan Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 WellMan Felypressin Product Portfolio
- 6.2.5 WellMan Recent Developments
- 6.3 TargetMol
- 6.3.1 TargetMol Company Information
- 6.3.2 TargetMol Business Overview
- 6.3.3 TargetMol Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 TargetMol Felypressin Product Portfolio
- 6.3.5 TargetMol Recent Developments
- 6.4 TaiTan
- 6.4.1 TaiTan Company Information
- 6.4.2 TaiTan Business Overview
- 6.4.3 TaiTan Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 TaiTan Felypressin Product Portfolio
- 6.4.5 TaiTan Recent Developments
- 6.5 Maclin
- 6.5.1 Maclin Company Information
- 6.5.2 Maclin Business Overview
- 6.5.3 Maclin Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Maclin Felypressin Product Portfolio
- 6.5.5 Maclin Recent Developments
- 6.6 Nanjing Peptide
- 6.6.1 Nanjing Peptide Company Information
- 6.6.2 Nanjing Peptide Business Overview
- 6.6.3 Nanjing Peptide Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Nanjing Peptide Felypressin Product Portfolio
- 6.6.5 Nanjing Peptide Recent Developments
- 6.7 Nanjing Leon
- 6.7.1 Nanjing Leon Company Information
- 6.7.2 Nanjing Leon Business Overview
- 6.7.3 Nanjing Leon Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Nanjing Leon Felypressin Product Portfolio
- 6.7.5 Nanjing Leon Recent Developments
- 6.8 JunYu
- 6.8.1 JunYu Company Information
- 6.8.2 JunYu Business Overview
- 6.8.3 JunYu Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 JunYu Felypressin Product Portfolio
- 6.8.5 JunYu Recent Developments
- 6.9 AikonChem
- 6.9.1 AikonChem Company Information
- 6.9.2 AikonChem Business Overview
- 6.9.3 AikonChem Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 AikonChem Felypressin Product Portfolio
- 6.9.5 AikonChem Recent Developments
- 6.10 JuSheng
- 6.10.1 JuSheng Company Information
- 6.10.2 JuSheng Business Overview
- 6.10.3 JuSheng Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 JuSheng Felypressin Product Portfolio
- 6.10.5 JuSheng Recent Developments
- 6.11 Sai Mannuo
- 6.11.1 Sai Mannuo Company Information
- 6.11.2 Sai Mannuo Business Overview
- 6.11.3 Sai Mannuo Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Sai Mannuo Felypressin Product Portfolio
- 6.11.5 Sai Mannuo Recent Developments
- 6.12 Gotopbio
- 6.12.1 Gotopbio Company Information
- 6.12.2 Gotopbio Business Overview
- 6.12.3 Gotopbio Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Gotopbio Felypressin Product Portfolio
- 6.12.5 Gotopbio Recent Developments
- 6.13 Mreda
- 6.13.1 Mreda Company Information
- 6.13.2 Mreda Business Overview
- 6.13.3 Mreda Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Mreda Felypressin Product Portfolio
- 6.13.5 Mreda Recent Developments
- 6.14 Vulcanchem
- 6.14.1 Vulcanchem Company Information
- 6.14.2 Vulcanchem Business Overview
- 6.14.3 Vulcanchem Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Vulcanchem Felypressin Product Portfolio
- 6.14.5 Vulcanchem Recent Developments
- 6.15 Toronto Research Chemicals
- 6.15.1 Toronto Research Chemicals Company Information
- 6.15.2 Toronto Research Chemicals Business Overview
- 6.15.3 Toronto Research Chemicals Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Toronto Research Chemicals Felypressin Product Portfolio
- 6.15.5 Toronto Research Chemicals Recent Developments
- 6.16 Medical Isotopes
- 6.16.1 Medical Isotopes Company Information
- 6.16.2 Medical Isotopes Business Overview
- 6.16.3 Medical Isotopes Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Medical Isotopes Felypressin Product Portfolio
- 6.16.5 Medical Isotopes Recent Developments
- 6.17 Glentham Life Sciences
- 6.17.1 Glentham Life Sciences Company Information
- 6.17.2 Glentham Life Sciences Business Overview
- 6.17.3 Glentham Life Sciences Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Glentham Life Sciences Felypressin Product Portfolio
- 6.17.5 Glentham Life Sciences Recent Developments
- 6.18 Crysdot
- 6.18.1 Crysdot Company Information
- 6.18.2 Crysdot Business Overview
- 6.18.3 Crysdot Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 6.18.4 Crysdot Felypressin Product Portfolio
- 6.18.5 Crysdot Recent Developments
- 6.19 ChemScene
- 6.19.1 ChemScene Company Information
- 6.19.2 ChemScene Business Overview
- 6.19.3 ChemScene Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 6.19.4 ChemScene Felypressin Product Portfolio
- 6.19.5 ChemScene Recent Developments
- 6.20 CacheSyn
- 6.20.1 CacheSyn Company Information
- 6.20.2 CacheSyn Business Overview
- 6.20.3 CacheSyn Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 6.20.4 CacheSyn Felypressin Product Portfolio
- 6.20.5 CacheSyn Recent Developments
- 6.21 BOC Sciences
- 6.21.1 BOC Sciences Company Information
- 6.21.2 BOC Sciences Business Overview
- 6.21.3 BOC Sciences Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 6.21.4 BOC Sciences Felypressin Product Portfolio
- 6.21.5 BOC Sciences Recent Developments
- 6.22 BIOTREND Chemicals AG
- 6.22.1 BIOTREND Chemicals AG Company Information
- 6.22.2 BIOTREND Chemicals AG Business Overview
- 6.22.3 BIOTREND Chemicals AG Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 6.22.4 BIOTREND Chemicals AG Felypressin Product Portfolio
- 6.22.5 BIOTREND Chemicals AG Recent Developments
7 North America by Country
- 7.1 North America Felypressin Sales by Country
- 7.1.1 North America Felypressin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Felypressin Sales by Country (2021-2026)
- 7.1.3 North America Felypressin Sales Forecast by Country (2027-2032)
- 7.2 North America Felypressin Market Size by Country
- 7.2.1 North America Felypressin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Felypressin Market Size by Country (2021-2026)
- 7.2.3 North America Felypressin Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Felypressin Sales by Country
- 8.1.1 Europe Felypressin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Felypressin Sales by Country (2021-2026)
- 8.1.3 Europe Felypressin Sales Forecast by Country (2027-2032)
- 8.2 Europe Felypressin Market Size by Country
- 8.2.1 Europe Felypressin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Felypressin Market Size by Country (2021-2026)
- 8.2.3 Europe Felypressin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Felypressin Sales by Country
- 9.1.1 Asia-Pacific Felypressin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Felypressin Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Felypressin Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Felypressin Market Size by Country
- 9.2.1 Asia-Pacific Felypressin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Felypressin Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Felypressin Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Felypressin Sales by Country
- 10.1.1 South America Felypressin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Felypressin Sales by Country (2021-2026)
- 10.1.3 South America Felypressin Sales Forecast by Country (2027-2032)
- 10.2 South America Felypressin Market Size by Country
- 10.2.1 South America Felypressin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Felypressin Market Size by Country (2021-2026)
- 10.2.3 South America Felypressin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Felypressin Sales by Country
- 11.1.1 Middle East and Africa Felypressin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Felypressin Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Felypressin Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Felypressin Market Size by Country
- 11.2.1 Middle East and Africa Felypressin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Felypressin Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Felypressin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Felypressin Value Chain Analysis
- 12.1.1 Felypressin Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Felypressin Production Mode & Process
- 12.2 Felypressin Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Felypressin Distributors
- 12.2.3 Felypressin Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst